Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.
New technique could help when cardiologists repair 2 leaky heart valves at once
Performing M-TEER and T-TEER on the same patient using a single guide catheter appears to be both safe and effective. Researchers shared their experience with this approach in Circulation: Cardiovascular Interventions.
‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations
The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.

Cancer patients are missing out on safe, effective heart attack treatments

The study's authors reviewed data from more than 1.8 million patients, confirming that PCI is still safe and effective when a patient has cancer.

PASCAL valve repair system still performing well for TR patients after 30 days

Overall, researchers wrote in the Journal of the American College of Cardiology, the PASCAL repair system has been working as it was intended.

Why STEMI patients undergoing PCI should be tested for subclinical hypothyroidism

For patients undergoing PCI, subclinical hypothyroidism was associated with higher short-term and long-term mortality.

Same-day discharge after PCI? American College of Cardiology shares a new guidance

Knowing when same-day discharge is the right choice—and when it isn’t—can be especially challenging for cardiologists and their care teams.

Edwards evaluating the safety, effectiveness of new mitral valve repair solution

The system was designed to require only one small incision to repair a patient’s mitral valve.

Statin therapy with evolocumab reduces patient’s risk of PCI, CABG

The authors tracked data from more than 1,700 patients with stable atherosclerosis, sharing their findings in the Journal of the American College of Cardiology.

Ticagrelor vs. prasugrel for severe heart attack patients undergoing PCI

A new study, published in Circulation, tracked how each drug helped STEMI patients undergoing primary PCI.

New technique for heart bypass surgery could limit patient discomfort, lower costs

The updated approach relies solely on CT imaging data and does not require a catheter.

Interventional Cardiology

FDA clears TAVR guidewire built with BASILICA in mind

New technique could help when cardiologists repair 2 leaky heart valves at once

‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

New physician Medicare payments for the Agent drug-coated balloon set for 2027